Marshall Wace North America’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.09M Buy
+16,788
New +$1.17M ﹤0.01% 894
2019
Q4
Sell
-2,094
Closed -$120K 1419
2019
Q3
$120K Sell
2,094
-29,068
-93% -$1.93M ﹤0.01% 1030
2019
Q2
$2.04M Buy
+31,162
New +$2.17M 0.01% 562
2018
Q1
Sell
-39,231
Closed -$1.83M 1544
2017
Q4
$1.83M Sell
39,231
-43,883
-53% -$2.17M 0.01% 853
2017
Q3
$4.24M Buy
+83,114
New +$3.87M 0.03% 593

Other funds holding HQY

Marshall Wace North America's HQY Position: Q3 2021 in Review

Marshall Wace North America opened a new position in HealthEquity (HQY) in Q3 2021: 16,788 shares worth $1.09M. The stake represents ﹤0.01% of the portfolio and ranks #894 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in HQY as recently as Q3 2019.

Marshall Wace North America first reported a position in HQY in Q3 2017 and has held it in 5 quarters since. The position peaked at $4.24M in Q3 2017. 286 funds tracked by Wall St. Rank hold HQY as of Q3 2021.

  • Marshall Wace North America held 16,788 shares of HealthEquity worth $1.09M as of Q3 2021.
  • HealthEquity was a new Marshall Wace North America position in Q3 2021.
  • HealthEquity made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #894 holding.
  • Marshall Wace North America first reported a position in HealthEquity in Q3 2017 and has held it in 5 quarters since.
  • Marshall Wace North America's HealthEquity position peaked at $4.24M in Q3 2017.
  • 286 funds tracked by Wall St. Rank held HealthEquity as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.